MGNX
MACROGENICS INC
Company overview
- Market capitalization
- $258.62M
- Employees
- 293
- Latest publication
- 2026-09-29
About MACROGENICS INC
MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule that targets an undisclosed antigen expressed across several solid tumors, which is in preclinical trials. It is also developing T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 32,832,000USD | 20,775,000USD | 41,227,000USD | 72,839,000USD | 22,241,000USD | 13,192,000USD | 17,730,000USD | 110,708,000USD |
| Cost Of Revenue | 0USD | 11,217,000USD | 11,820,000USD | 13,378,000USD | 10,813,000USD | 7,171,000USD | 5,490,000USD | 42,413,000USD |
| Gross Profit | 32,832,000USD | 9,558,000USD | 29,407,000USD | 59,461,000USD | 11,428,000USD | 6,021,000USD | 12,240,000USD | 68,295,000USD |
| Research Development | 38,780,000USD | 33,287,000USD | 32,269,000USD | 30,920,000USD | 38,884,000USD | 37,927,000USD | 38,890,000USD | 40,543,000USD |
| Selling General Administrative | 7,904,000USD | 9,710,000USD | 9,235,000USD | 9,905,000USD | 9,302,000USD | 10,718,000USD | 27,810,000USD | 14,104,000USD |
| General And Administrative Expenses | 7,904,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 46,684,000USD | 42,997,000USD | 41,504,000USD | 40,825,000USD | 48,186,000USD | 48,645,000USD | 65,077,000USD | 14,104,000USD |
| Operating Income | -13,852,000USD | -33,439,000USD | -12,097,000USD | 18,636,000USD | -36,758,000USD | -42,624,000USD | -52,837,000USD | 54,191,000USD |
| Total Other Income Expense Net | -55,790,000USD | -3,335,000USD | -2,835,000USD | -1,814,000USD | 612,000USD | 1,588,000USD | 38,360,000USD | 2,118,000USD |
| Interest Expense | 4,396,000USD | 4,889,000USD | 4,272,000USD | 3,342,000USD | 802,000USD | 91,000USD | 24,000USD | 0USD |
| Income Before Tax | -69,642,000USD | -36,774,000USD | -14,932,000USD | 16,822,000USD | -36,146,000USD | -41,036,000USD | -14,477,000USD | 56,309,000USD |
| Income Tax Expense | 0USD | — | -777,000USD | — | 105,000USD | — | 944,000USD | -1,835,000USD |
| Discontinued Operations | 89,157,000USD | — | — | — | — | — | — | — |
| Net Income | 19,515,000USD | -36,774,000USD | -14,155,000USD | 16,822,000USD | -36,251,000USD | -41,036,000USD | -15,421,000USD | 56,309,000USD |
| Interest Income | — | 1,554,000USD | 1,437,000USD | 1,528,000USD | 1,414,000USD | 1,679,000USD | 2,086,000USD | 2,118,000USD |
| Net Interest Income | — | -3,335,000USD | -2,835,000USD | -1,814,000USD | 612,000USD | 1,588,000USD | 2,110,000USD | 2,118,000USD |
| Net Income From Continuing Ops | — | -36,774,000USD | -14,155,000USD | 16,822,000USD | -36,251,000USD | -41,036,000USD | -15,421,000USD | 56,309,000USD |
| Ebit | — | -33,439,000USD | -12,097,000USD | 18,636,000USD | -36,758,000USD | -42,624,000USD | -14,501,000USD | 54,191,000USD |
| Ebitda | — | -31,752,000USD | -10,392,000USD | 20,425,000USD | -34,851,000USD | -40,853,000USD | -12,448,000USD | 56,026,000USD |
| Depreciation And Amortization | — | 1,687,000USD | 1,705,000USD | 1,789,000USD | 1,907,000USD | 1,771,000USD | 2,053,000USD | 1,835,000USD |
| Reconciled Depreciation | — | 1,687,000USD | 1,705,000USD | 1,789,000USD | 1,907,000USD | 1,771,000USD | 2,053,000USD | 1,835,000USD |
| Tax Provision | — | — | -777,000USD | 0USD | 105,000USD | — | — | 0USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -1,623,000USD | -40,543,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 149,500,000USD | 148,339,000USD | 57,193,000USD | 151,941,000USD | 75,643,000USD | 97,764,000USD | 62,024,000USD | 60,121,000USD |
| Cost Of Revenue | 43,181,000USD | 12,299,000USD | 8,222,000USD | 7,384,000USD | 2,651,000USD | 193,201,000USD | 195,309,000USD | 190,827,000USD |
| Gross Profit | 106,319,000USD | 136,040,000USD | 48,971,000USD | 144,557,000USD | 72,992,000USD | 97,764,000USD | 62,024,000USD | 60,121,000USD |
| Research Development | 140,000,000USD | 177,194,000USD | 166,583,000USD | 207,026,000USD | 214,577,000USD | 193,201,000USD | 195,309,000USD | 190,827,000USD |
| Selling General Administrative | 39,160,000USD | 71,047,000USD | 52,188,000USD | 58,949,000USD | 63,014,000USD | 42,742,000USD | 46,064,000USD | 40,500,000USD |
| Total Operating Expenses | 179,160,000USD | 246,618,000USD | 217,215,000USD | 265,975,000USD | 275,787,000USD | 228,824,000USD | 239,209,000USD | 231,327,000USD |
| Operating Income | -72,841,000USD | -110,578,000USD | -168,244,000USD | -121,418,000USD | -202,795,000USD | -131,060,000USD | -177,185,000USD | -171,206,000USD |
| Interest Income | 6,057,000USD | 9,421,000USD | 9,686,000USD | 1,660,000USD | 680,000USD | — | — | — |
| Interest Expense | 8,508,000USD | 1,115,000USD | 1,430,000USD | 263,000USD | 680,000USD | 0USD | 0USD | 0USD |
| Net Interest Income | -2,451,000USD | 8,306,000USD | 8,256,000USD | 1,660,000USD | 680,000USD | — | — | — |
| Income Before Tax | -75,292,000USD | -66,022,000USD | -9,058,000USD | -119,758,000USD | -202,115,000USD | -129,739,000USD | -151,811,000USD | -171,453,000USD |
| Income Tax Expense | -672,000USD | 944,000USD | 9,477,105USD | 263,000USD | -11,258,000USD | -11,957,000USD | 10,673,140USD | -247,000USD |
| Tax Provision | -672,000USD | 944,000USD | 0USD | 0USD | — | — | — | — |
| Net Income | -74,620,000USD | -66,966,000USD | -9,058,000USD | -120,021,000USD | -190,857,000USD | -117,782,000USD | -151,811,000USD | -171,453,000USD |
| Net Income From Continuing Ops | -74,620,000USD | -66,966,000USD | -9,058,000USD | -119,758,000USD | -202,115,000USD | -129,739,000USD | -151,811,000USD | -171,453,000USD |
| Ebit | -72,841,000USD | -64,907,000USD | -7,628,000USD | -121,418,000USD | -202,795,000USD | -131,060,000USD | -177,185,000USD | -171,246,000USD |
| Ebitda | -65,669,000USD | -57,367,000USD | 2,017,000USD | -109,553,000USD | -191,537,000USD | -119,103,000USD | -164,879,000USD | -162,046,000USD |
| Depreciation And Amortization | 7,172,000USD | 7,540,000USD | 9,645,000USD | 11,865,000USD | 11,258,000USD | 11,957,000USD | 12,306,000USD | 9,200,000USD |
| Reconciled Depreciation | 7,172,000USD | 7,540,000USD | 9,645,000USD | 11,865,000USD | 11,258,000USD | 11,957,000USD | 10,845,000USD | 8,279,000USD |
| Total Other Income Expense Net | -2,451,000USD | 44,556,000USD | 159,186,000USD | 1,660,000USD | 680,000USD | 1,321,000USD | 25,374,000USD | -247,000USD |
| Non Operating Income Net Other | — | — | — | 1,660,000USD | 680,000USD | 1,321,000USD | — | -247,000USD |
| Net Income Applicable To Common Shares | — | — | — | -119,758,000USD | -202,115,000USD | -129,739,000USD | -151,811,000USD | -171,453,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | -7,119,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 345,409,000USD | 217,873,000USD | 256,846,000USD | 270,763,000USD | 245,416,000USD | 224,565,000USD | 261,655,000USD | 264,492,000USD |
| Cash And Equivalents | 113,907,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 321,687,000USD | 182,523,000USD | 219,941,000USD | 232,091,000USD | 204,945,000USD | 182,088,000USD | 217,490,000USD | 222,196,000USD |
| Other Current Assets | 4,209,000USD | 8,371,000USD | 8,745,000USD | 7,714,000USD | 6,652,000USD | 7,978,000USD | 11,514,000USD | 9,839,000USD |
| Other Non Current Assets | 195,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 302,536,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 108,815,000USD | 95,940,000USD | 43,115,000USD | 44,470,000USD | 39,000,000USD | 55,441,000USD | 55,530,000USD | 59,309,000USD |
| Other Current Liabilities | 29,902,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 450,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 42,873,000USD | 21,198,000USD | 55,591,000USD | 67,001,000USD | 46,618,000USD | 79,119,000USD | 116,057,000USD | 120,066,000USD |
| Total Equity Including Noncontrolling Interest | 42,873,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 55,503,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 0USD | — | — | — | — | — | — | — |
| Net Receivables | 24,597,000USD | 10,425,000USD | 13,373,000USD | 69,230,000USD | 12,532,000USD | 10,543,000USD | 4,309,000USD | 8,750,000USD |
| Property Plant Equipment Net | 23,527,000USD | 33,974,000USD | 35,520,000USD | 37,280,000USD | 39,074,000USD | 40,987,000USD | 42,609,000USD | 41,111,000USD |
| Accounts Payable | 3,442,000USD | 4,287,000USD | 4,787,000USD | 5,940,000USD | 4,657,000USD | 6,617,000USD | 5,013,000USD | 6,613,000USD |
| Short Term Debt | 4,976,000USD | 5,214,000USD | 5,177,000USD | 5,141,000USD | 5,122,000USD | 5,367,000USD | 4,864,000USD | 4,744,000USD |
| Common Stock | 637,000USD | 636,000USD | 633,000USD | 633,000USD | 632,000USD | 631,000USD | 628,000USD | 627,000USD |
| Retained Earnings | -1,261,597,000USD | -1,281,112,000USD | -1,244,338,000USD | -1,230,183,000USD | -1,247,005,000USD | -1,210,754,000USD | -1,169,718,000USD | -1,154,297,000USD |
| Total Liab | — | 196,675,000USD | 201,255,000USD | 203,762,000USD | 198,798,000USD | 145,446,000USD | 145,598,000USD | 144,426,000USD |
| Other Current Liab | — | 18,446,000USD | 22,230,000USD | 23,087,000USD | 21,349,000USD | 27,837,000USD | 29,334,000USD | 24,644,000USD |
| Capital Stock | — | 636,000USD | 633,000USD | 633,000USD | 632,000USD | 631,000USD | 628,000USD | 627,000USD |
| Cash | — | 66,517,000USD | 57,217,000USD | 80,129,000USD | 130,686,000USD | 145,570,000USD | 182,840,000USD | 179,625,000USD |
| Cash And Short Term Investments | — | 154,229,000USD | 189,913,000USD | 146,397,000USD | 176,486,000USD | 154,141,000USD | 201,667,000USD | 200,363,000USD |
| Current Deferred Revenue | — | 67,993,000USD | 10,921,000USD | 10,302,000USD | 7,872,000USD | 15,620,000USD | 16,319,000USD | 23,308,000USD |
| Net Debt | — | -30,008,000USD | 49,545,000USD | -43,120,000USD | -23,179,000USD | -108,104,000USD | -145,379,000USD | -145,525,000USD |
| Short Long Term Debt Total | — | 36,509,000USD | 106,762,000USD | 37,009,000USD | 107,507,000USD | 37,466,000USD | 37,461,000USD | 34,100,000USD |
| Short Term Investments | — | 87,712,000USD | 132,696,000USD | 66,268,000USD | 45,800,000USD | 8,571,000USD | 18,827,000USD | 20,738,000USD |
| Inventory | — | 9,498,000USD | 7,910,000USD | 8,750,000USD | 9,275,000USD | 9,426,000USD | 0USD | 3,244,000USD |
| Property Plant Equipment Gross | — | 33,974,000USD | 131,327,000USD | 37,280,000USD | 39,074,000USD | 40,987,000USD | 131,296,000USD | 41,111,000USD |
| Accumulated Other Comprehensive Income | — | -27,000USD | 32,000USD | 5,000USD | -7,000USD | -1,000USD | 4,000USD | 14,000USD |
| Common Stock Shares Outstanding | — | 63,449,780shares | 63,155,096shares | 63,283,624shares | 63,136,057shares | 62,965,415shares | 62,621,185shares | 62,865,841shares |
| Non Current Assets Total | — | 35,350,000USD | 36,905,000USD | 38,672,000USD | 40,471,000USD | 42,477,000USD | 53,065,000USD | 42,296,000USD |
| Non Current Liabilities Total | — | 100,735,000USD | 158,140,000USD | 159,292,000USD | 159,798,000USD | 90,005,000USD | 98,968,000USD | 85,117,000USD |
| Non Current Liabilities Other | — | 69,440,000USD | 71,052,000USD | 71,584,000USD | 71,928,000USD | 1,968,000USD | 1,968,000USD | 258,000USD |
| Non Currrent Assets Other | — | 1,376,000USD | 1,385,000USD | 1,392,000USD | 1,397,000USD | 1,490,000USD | 10,456,000USD | 1,185,000USD |
| Net Working Capital | — | 86,583,000USD | 176,826,000USD | 187,621,000USD | 165,945,000USD | 126,647,000USD | 161,960,000USD | 162,887,000USD |
| Unclassified Non Current Liabilities | — | 31,295,000USD | 87,088,000USD | 87,708,000USD | 87,870,000USD | 88,037,000USD | 97,000,000USD | 84,859,000USD |
| Unclassified Equity | — | 1,301,065,000USD | 1,298,631,000USD | 1,295,913,000USD | 1,292,366,000USD | 1,288,612,000USD | 1,284,515,000USD | 1,273,095,000USD |
| Other Assets | — | — | — | — | — | — | -8,900,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 256,846,000USD | 261,655,000USD | 298,418,000USD | 289,511,000USD | 335,245,000USD | 378,743,000USD | 312,501,000USD | 332,130,000USD |
| Other Current Assets | 8,745,000USD | 11,514,000USD | 9,946,000USD | 10,161,000USD | 21,170,000USD | 16,982,000USD | 11,285,000USD | 6,406,000USD |
| Total Liab | 201,255,000USD | 145,598,000USD | 145,805,000USD | 147,498,000USD | 95,627,000USD | 82,859,000USD | 81,873,000USD | 89,253,000USD |
| Total Stockholder Equity | 55,591,000USD | 116,057,000USD | 152,613,000USD | 142,013,000USD | 239,618,000USD | 295,884,000USD | 230,628,000USD | 242,877,000USD |
| Other Current Liab | 22,230,000USD | 29,334,000USD | 24,239,000USD | 28,998,000USD | 54,401,000USD | 38,654,000USD | 37,839,000USD | 34,214,000USD |
| Common Stock | 633,000USD | 628,000USD | 621,000USD | 617,000USD | 613,000USD | 562,000USD | 490,000USD | 424,000USD |
| Capital Stock | 633,000USD | 628,000USD | 621,000USD | 617,000USD | 613,000USD | 562,000USD | 490,000USD | 424,000USD |
| Retained Earnings | -1,244,338,000USD | -1,169,718,000USD | -1,102,752,000USD | -1,093,694,000USD | -973,936,000USD | -771,821,000USD | -642,082,000USD | -490,271,000USD |
| Cash | 57,217,000USD | 182,840,000USD | 100,956,000USD | 108,884,000USD | 123,469,000USD | 181,131,000USD | 126,472,000USD | 220,128,000USD |
| Cash And Short Term Investments | 189,913,000USD | 201,667,000USD | 229,805,000USD | 154,346,000USD | 243,616,000USD | 272,531,000USD | 215,756,000USD | 232,863,000USD |
| Total Current Assets | 219,941,000USD | 217,490,000USD | 251,339,000USD | 222,180,000USD | 279,560,000USD | 312,594,000USD | 239,785,000USD | 269,124,000USD |
| Total Current Liabilities | 43,115,000USD | 55,530,000USD | 56,108,000USD | 48,611,000USD | 74,578,000USD | 50,673,000USD | 45,167,000USD | 59,940,000USD |
| Current Deferred Revenue | 10,921,000USD | 16,319,000USD | 21,651,000USD | 9,988,000USD | 20,646,000USD | 11,382,000USD | 10,700,000USD | 21,721,000USD |
| Net Debt | 49,545,000USD | -145,379,000USD | -66,985,000USD | -74,052,000USD | -98,001,000USD | -151,883,000USD | -95,899,000USD | -220,128,000USD |
| Short Term Debt | 5,177,000USD | 4,864,000USD | 3,775,000USD | 4,726,000USD | 4,677,000USD | 3,988,000USD | 3,020,000USD | 34,039,000USD |
| Short Long Term Debt Total | 106,762,000USD | 37,461,000USD | 33,971,000USD | 34,832,000USD | 25,468,000USD | 29,248,000USD | 30,573,000USD | — |
| Short Term Investments | 132,696,000USD | 18,827,000USD | 128,849,000USD | 45,462,000USD | 120,147,000USD | 91,400,000USD | 89,284,000USD | 12,735,000USD |
| Net Receivables | 13,373,000USD | 4,309,000USD | 10,367,000USD | 56,222,000USD | 10,386,000USD | 23,081,000USD | 12,744,000USD | 29,583,000USD |
| Inventory | 7,910,000USD | 0USD | 1,221,000USD | 1,451,000USD | 4,388,000USD | 1USD | 1USD | — |
| Accounts Payable | 4,787,000USD | 5,013,000USD | 6,443,000USD | 4,899,000USD | 15,500,000USD | 8,031,000USD | 4,308,000USD | 4,005,000USD |
| Property Plant Equipment Net | 35,520,000USD | 42,609,000USD | 45,693,000USD | 56,910,000USD | 54,290,000USD | 61,525,000USD | 68,411,000USD | 56,712,000USD |
| Property Plant Equipment Gross | 131,327,000USD | 131,296,000USD | 134,087,000USD | 29,575,000USD | 110,485,000USD | 42,225,000USD | 48,211,000USD | 56,712,000USD |
| Accumulated Other Comprehensive Income | 32,000USD | 4,000USD | -6,000USD | -5,000USD | -61,000USD | -7,000USD | 15,999USD | -3,000USD |
| Common Stock Shares Outstanding | 63,155,096shares | 62,621,185shares | 61,929,198shares | 61,433,124shares | 59,944,717shares | 52,442,389shares | 48,082,728shares | 40,925,318shares |
| Non Current Assets Total | 36,905,000USD | 53,065,000USD | 47,079,000USD | 67,331,000USD | 55,685,000USD | 66,149,000USD | 72,716,000USD | 63,006,000USD |
| Non Current Liabilities Total | 158,140,000USD | 98,968,000USD | 89,697,000USD | 98,887,000USD | 21,049,000USD | 32,186,000USD | 36,706,000USD | 29,313,000USD |
| Non Current Liabilities Other | 71,052,000USD | 1,968,000USD | 258,000USD | 258,000USD | 258,000USD | 25,260,000USD | — | — |
| Non Currrent Assets Other | 1,385,000USD | 10,456,000USD | 1,386,000USD | 1,378,000USD | 1,395,000USD | 4,624,000USD | 4,305,000USD | 6,294,000USD |
| Net Working Capital | 176,826,000USD | 161,960,000USD | 195,231,000USD | 173,569,000USD | 204,982,000USD | 261,921,000USD | 194,618,000USD | 209,184,000USD |
| Unclassified Non Current Liabilities | 87,088,000USD | 97,000,000USD | 89,439,000USD | -20,589,000USD | 20,533,000USD | -6,926,000USD | 27,553,000USD | -29,313,000USD |
| Unclassified Equity | 1,298,631,000USD | 1,284,515,000USD | 1,254,129,000USD | 1,234,478,000USD | 1,212,389,000USD | 1,066,588,000USD | 871,714,001USD | 732,303,000USD |
| Other Assets | — | -8,900,000USD | 1USD | 1,378,000USD | 335,245,000USD | 23,924,000USD | 4,305,000USD | 6,292,100USD |
| Deferred Long Term Liab | — | — | — | 59,480,000USD | — | 6,926,000USD | — | 29,313,000USD |
| Other Liab | — | — | — | 59,738,000USD | 258,000USD | 6,926,000USD | 9,153,000USD | 29,313,000USD |
| Net Tangible Assets | — | — | — | 142,013,000USD | 239,618,000USD | 295,884,000USD | 230,628,000USD | 242,877,000USD |
| Unclassified Non Current Assets | — | — | — | 7,665,000USD | -335,245,000USD | -23,924,000USD | -6,205,000USD | -6,294,000USD |
| Unclassified Current Liabilities | — | — | — | — | -20,646,000USD | -11,382,000USD | -10,700,000USD | -34,039,000USD |
| Long Term Investments | — | — | — | — | — | — | 1,900,000USD | 1,900USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,395,000USD |
| Stock Based Compensation | 4,620,000USD |
| Change To Account Receivables | -23,002,000USD |
| Change To Inventory | -1,242,000USD |
| Change To Liabilities | 6,779,000USD |
| Change In Working Capital | -23,061,000USD |
| Operating Cash Flow | -76,559,000USD |
| Capital Expenditures | -1,150,000USD |
| Net Investments | 74,433,000USD |
| Investing Cash Flow | 73,283,000USD |
| Net Common Stock Issuance | -218,000USD |
| Unclassified Financing Cash Flow | 60,184,000USD |
| Financing Cash Flow | 59,966,000USD |
| Change In Cash | 56,690,000USD |
| End Cash Flow | 113,907,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -36,774,000USD | -14,155,000USD | 16,822,000USD | -36,251,000USD | -41,036,000USD | -15,421,000USD | 56,309,000USD | -55,664,000USD |
| Depreciation | 1,687,000USD | 1,554,000USD | 1,789,000USD | 1,907,000USD | 1,771,000USD | 2,053,000USD | 1,835,000USD | 1,811,000USD |
| Stock Based Compensation | 2,646,000USD | 2,661,000USD | 3,549,000USD | 3,690,000USD | 4,386,000USD | 11,265,000USD | 5,970,000USD | 6,651,000USD |
| Other Non Cash Items | 1,046,000USD | -179,000USD | -110,000USD | 676,000USD | 217,000USD | -38,933,000USD | 160,000USD | -307,000USD |
| Change To Account Receivables | 2,947,000USD | 55,858,000USD | -56,698,000USD | -1,990,000USD | -6,233,000USD | 4,442,000USD | -2,560,000USD | 1,028,000USD |
| Change To Inventory | -1,589,000USD | 840,000USD | 525,000USD | 151,000USD | -9,426,000USD | -165,000USD | -2,129,000USD | 133,000USD |
| Change In Working Capital | -1,770,000USD | 53,140,000USD | -52,236,000USD | -17,007,000USD | -12,228,000USD | 2,629,000USD | -4,112,000USD | 3,024,000USD |
| Total Cash From Operating Activities | -35,811,000USD | 43,021,000USD | -30,186,000USD | -46,985,000USD | -46,890,000USD | -38,407,000USD | 60,162,000USD | -44,485,000USD |
| Capital Expenditures | -344,000USD | -244,000USD | -426,000USD | -715,000USD | -529,000USD | -620,000USD | -592,000USD | -1,035,000USD |
| Free Cash Flow | -36,155,000USD | 42,777,000USD | -30,612,000USD | -47,700,000USD | -47,419,000USD | -39,027,000USD | 59,570,000USD | -45,520,000USD |
| Investments | 45,662,000USD | -65,757,000USD | -20,371,000USD | -37,638,000USD | 9,902,000USD | 41,467,000USD | 35,599,000USD | 47,437,000USD |
| Total Cashflows From Investing Activities | 45,318,000USD | -65,990,000USD | -20,371,000USD | -37,638,000USD | 9,902,000USD | 41,467,000USD | 35,599,000USD | 47,437,000USD |
| Total Cash From Financing Activities | -207,000USD | 57,000USD | 0USD | 69,739,000USD | -282,000USD | 155,000USD | -68,000USD | 625,000USD |
| Change In Cash | 9,299,999USD | -22,912,000USD | -50,557,000USD | -14,884,000USD | -37,270,000USD | 3,215,000USD | 95,693,000USD | 3,577,000USD |
| Begin Period Cash Flow | 57,217,000USD | 80,129,000USD | 130,686,000USD | 145,570,000USD | 182,840,000USD | 179,625,000USD | 83,932,000USD | 80,355,000USD |
| End Period Cash Flow | 66,516,999USD | 57,217,000USD | 80,129,000USD | 130,686,000USD | 145,570,000USD | 182,840,000USD | 179,625,000USD | 83,932,000USD |
| Other Cashflows From Financing Activities | -218,000USD | 69,667,000USD | — | — | -282,000USD | -4,000USD | -74,000USD | 625,000USD |
| Unclassified Operating Cash Flow | -2,646,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | 11,000USD | — | — | — | 40,080,000USD | 160,000USD | 80,000USD |
| Unclassified Financing Cash Flow | — | -69,610,000USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | -39,460,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -74,620,000USD | -66,966,000USD | -9,058,000USD | -119,758,000USD | -202,115,000USD | -129,739,000USD | -151,811,000USD | -171,453,000USD |
| Depreciation | 5,524,000USD | 7,540,000USD | 9,645,000USD | 11,865,000USD | 11,258,000USD | 11,957,000USD | 10,845,000USD | 8,279,000USD |
| Stock Based Compensation | 14,286,000USD | 29,439,000USD | 18,373,000USD | 20,438,000USD | 23,126,000USD | 20,676,000USD | 19,571,000USD | 16,520,000USD |
| Other Non Cash Items | 2,101,000USD | -39,778,000USD | -150,481,000USD | 6,626,000USD | 6,332,000USD | -260,000USD | 25,090,000USD | 48,386,000USD |
| Change To Account Receivables | -9,063,000USD | 6,058,000USD | 45,855,000USD | -45,836,000USD | 12,696,000USD | -10,337,000USD | 16,839,000USD | -15,941,000USD |
| Change To Inventory | -7,910,000USD | -2,188,000USD | 230,000USD | 55,000USD | -6,424,000USD | 554,000USD | -9,632,000USD | -4,627,000USD |
| Change In Working Capital | -28,331,000USD | 1,392,000USD | 53,316,000USD | -6,130,000USD | 17,569,000USD | -14,532,000USD | -12,875,000USD | -6,580,000USD |
| Total Cash From Operating Activities | -81,040,000USD | -68,373,000USD | -78,205,000USD | -86,959,000USD | -143,830,000USD | -111,898,000USD | -134,270,000USD | -153,234,000USD |
| Capital Expenditures | -1,914,000USD | -3,706,000USD | -1,764,000USD | -3,623,000USD | -6,201,000USD | -5,906,000USD | -4,289,000USD | -24,954,000USD |
| Free Cash Flow | -82,954,000USD | -72,079,000USD | -79,969,000USD | -90,582,000USD | -150,031,000USD | -117,804,000USD | -138,559,000USD | -178,188,000USD |
| Investments | -112,194,000USD | 149,297,000USD | -80,084,000USD | 74,338,000USD | -30,408,000USD | -1,879,000USD | -79,358,000USD | 81,598,000USD |
| Total Cashflows From Investing Activities | -114,097,000USD | 149,297,000USD | -80,084,000USD | 70,715,000USD | -36,609,000USD | -7,785,000USD | -79,358,000USD | 56,644,000USD |
| Total Cash From Financing Activities | 69,514,000USD | 960,000USD | 150,361,000USD | 1,659,000USD | 122,777,000USD | 174,342,000USD | 119,972,000USD | 104,991,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 616,000USD | 1,085,000USD | 117,818,000USD | 170,456,000USD | 118,657,000USD | 103,259,000USD |
| Change In Cash | -125,623,000USD | 81,884,000USD | -7,928,000USD | -14,585,000USD | -57,662,000USD | 54,659,000USD | -93,656,000USD | 8,401,000USD |
| Begin Period Cash Flow | 182,840,000USD | 100,956,000USD | 108,884,000USD | 123,469,000USD | 181,131,000USD | 126,472,000USD | 220,128,000USD | 211,727,000USD |
| End Period Cash Flow | 57,217,000USD | 182,840,000USD | 100,956,000USD | 108,884,000USD | 123,469,000USD | 181,131,000USD | 126,472,000USD | 220,128,000USD |
| Other Cashflows From Investing Activities | 11,000USD | 40,160,000USD | 64,000USD | 74,338,000USD | -30,408,000USD | -1,879,000USD | -75,069,000USD | 81,598,000USD |
| Other Cashflows From Financing Activities | 69,385,000USD | 960,000USD | 149,349,000USD | 574,000USD | 4,959,000USD | 3,886,000USD | 1,315,000USD | 1,992,000USD |
| Unclassified Investing Cash Flow | — | -36,454,000USD | 1,700,000USD | -74,338,000USD | 30,408,000USD | 1,879,000USD | 79,358,000USD | -81,598,000USD |
| Sale Purchase Of Stock | — | — | -306,000USD | 1,085,000USD | 117,818,000USD | -2,012,000USD | 0USD | -260,000USD |
| Change To Liabilities | — | — | — | -15,498,000USD | 6,518,000USD | 10,717,000USD | -20,082,000USD | 14,661,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -14,585,000USD | -57,662,000USD | 54,659,000USD | — | 8,401,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | 172,468,000USD | 118,657,000USD | 103,259,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -25,090,000USD | -48,386,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2025Quarterly · 2025-03-31 | Product | Contract Manufacturing | 6,150,000 | USD | 0001125345-26-000038 |
| Q1 2025Quarterly · 2025-03-31 | Product | Manufacturing Services — Revenue From Royality Agreements Member | 400,000 | USD | 0001125345-26-000038 |
| Q1 2025Quarterly · 2025-03-31 | Product | Manufacturing Services — Revenues From License Agreements | 800,000 | USD | 0001125345-26-000038 |
| Q1 2025Quarterly · 2025-03-31 | Product | Other | 842,000 | USD | 0001125345-26-000038 |
| Q1 2025Quarterly · 2025-03-31 | Product | Revenues From CMOAgreements Member | 5,000,000 | USD | 0001125345-26-000038 |
| Q3 2024Quarterly · 2024-09-30 | Product | Contract Manufacturing | 4,573,000 | USD | 0001125345-24-000160 |
| Q3 2024Quarterly · 2024-09-30 | Product | Government Contract | 566,000 | USD | 0001125345-24-000160 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenue From Collaborative Agreements | 101,408,000 | USD | 0001125345-24-000160 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenues From CMOAgreements Member | 3,800,000 | USD | 0001125345-24-000160 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenues From Grants | 600,000 | USD | 0001125345-24-000160 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenues From License Agreements | 600,000 | USD | 0001125345-24-000160 |
| Q2 2022Quarterly · 2022-06-30 | Product | Contract Manufacturing | 3,992,000 | USD | 0001125345-23-000108 |
| Q2 2022Quarterly · 2022-06-30 | Product | Revenue From Collaborative Agreements | 16,863,000 | USD | 0001125345-23-000108 |
| Q2 2022Quarterly · 2022-06-30 | Product | Revenue From Government Agreements | 480,000 | USD | 0001125345-23-000108 |
| Q2 2022Quarterly · 2022-06-30 | Product | Revenue From Royality Agreements Member | 0 | USD | 0001125345-23-000108 |
| Q2 2022Quarterly · 2022-06-30 | Product | Revenues From CMOAgreements Member | 4,000,000 | USD | 0001125345-23-000108 |
| Q2 2022Quarterly · 2022-06-30 | Product | Revenues From Grants | 500,000 | USD | 0001125345-23-000108 |
| Q2 2022Quarterly · 2022-06-30 | Product | Revenues From License Agreements | 200,000 | USD | 0001125345-23-000108 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.